Open AccessRoflumilast, a type of phosphodiesterase 4 inhibitor, can reduce intestinal injury caused by sepsis
Author(s) -
Zhongyuan Zhang,
Meifeng Liang,
Xiongfei Wan
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10834
Subject(s) - sepsis , roflumilast , inflammation , apoptosis , immunology , lipopolysaccharide , tumor necrosis factor alpha , phosphodiesterase inhibitor , medicine , cytokine , pharmacology , biology , biochemistry , copd